市場調查報告書

全球腸內營養市場:到2027年的行業趨勢和預測

Global Enteral Feeding Formula Market - Industry Trends and Forecast to 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 949340
出版日期 內容資訊 英文 260 Pages
商品交期: 最快1-2個工作天內
價格
全球腸內營養市場:到2027年的行業趨勢和預測 Global Enteral Feeding Formula Market - Industry Trends and Forecast to 2027
出版日期: 2020年06月01日內容資訊: 英文 260 Pages
簡介

在2020年至2027年的預測期內,全球腸內營養市場預計將以6.7%的複合年增長率增長。該市場的主要增長因素是慢性病的發病率增加以及技術和產品創新的發展。

本報告按市場增長和限制,挑戰與機遇,產品/用途,管飼類型,年齡組,最終用戶和按區域劃分的市場對全球腸內營養市場進行了調查。我們提供的信息包括分析,競爭狀況和主要公司的概況。

內容

第1章簡介

第2章市場細分

第3章執行摘要

第4章重要注意事項

第5章市場概述

  • 生長因子
    • 早產增加
    • 慢性病增加
    • 擴大營養供應的增長業務
    • 老年人對營養保健的需求不斷增長
    • 對家庭護理的需求很高
  • 抑制因子
    • 與管飼有關的風險
    • 嚴格遵守使用規定以確保患者安全
    • 醫護人員臨床營養知識不足
  • 市場機會
    • 新興國家醫療費用的增長
    • 腸內飼餵系統的技術進步
    • 提高意識的政府舉措和計劃
    • 對個性化藥物的需求增加
  • 挑戰
    • 兌換政策不足
    • 缺乏訓練有素的員工

第6章COVID-19的影響

第7章市場分析:按產品

  • 概述
  • 標準配方
    • 單體
    • 聚合物
  • 特定疾病
    • 糖尿病
    • 腎病
    • 肝病
    • 肺炎
    • 其他

第8章市場分析:按應用

  • 概述
  • 重症監護
  • 胃腸道
  • 腫瘤
  • 神經
  • 糖尿病
  • 其他

第9章按管飼類型進行的市場分析

  • 概述
  • 滿管
  • 鼻胃管飼餵
  • 胃管飼餵
  • 十二指腸或空腸的管飼

第10章市場分析:按年齡段分組

  • 概述
  • 成人
  • 兒童

第11章最終用戶的市場分析

  • 概述
  • 醫院
  • 長期護理機構
    • 家庭醫療機構/臨終關懷
    • 療養院
    • 生活支援設施

第12章按地區進行市場分析

  • 世界
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 瑞士
    • 荷蘭
    • 挪威
    • 比利時
    • 俄羅斯
    • 波蘭
    • 土耳其
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 其他
  • 中東/非洲
    • 南非
    • 其他

第13章競爭情況

  • 公司佔有率分析:全球
  • 公司佔有率分析:歐洲
  • 公司佔有率分析:北美
  • 公司佔有率分析:亞太地區

第14章SWOT分析

第15章公司簡介

  • ABBOTT
  • NESTLE HEALTH SCIENCE
  • MEIJI HOLDINGS CO., LTD.
  • B. BRAUN MELSUNGEN AG
  • FRESENIUS KABI LTD (A SUBSIDIARY OF FRESENIUS SE & CO. KGAA)
  • GLOBAL HEALTH PRODUCTS, INC.
  • HORMEL FOODS CORPORATION
  • MEAD JOHNSON & COMPANY, LLC.
  • MEDLINE INDUSTRIES, INC
  • MEDTRITION, INC.
  • NUTRICIA ADVANCED MEDICAL NUTRITION
  • NUTRITIONAL MEDICINALS, LLC
  • REAL FOOD BLENDS
  • VICTUS, INC

第16章調查

第17章相關報告

目錄

Global enteral feeding formula market is projected to register a CAGR of 6.7% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation:

Global Enteral Feeding Formula Market, By Product (Standard Formulas and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals and Long Term Care Facilities), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, Poland and Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil, Argentina, Columbia, Chile and rest of South America, South Africa and Rest of Middle East and Africa) Industry Trends & Forecast to 2027

Some of the major factors contributing to the growth of the global enteral feeding formula market are:

Rising incidence of chronic diseases

Increasing evolution in technology and product innovation

Market Players:

The key market players for global enteral feeding formula market are listed below:

Nutricia Advanced Medical Nutrition

Hormel Foods Corporation

Victus, Inc.

Global Health Products, Inc.

Medline Industries, Inc

Mead Johnson & Company, LLC.

Medtrition, Inc.

Nutritional Medicinals, LLC

Real Food Blends

Nestle Health Science

Abbott

Meiji Holdings Co., Ltd.

Fresenius Kabi Ltd (A subsidiary of Fresenius SE & Co. KGaA)

B. Braun Melsungen AG

TABLE OF CONTENTS

1 INTRODUCTION 28

  • 1.1 OBJECTIVES OF THE STUDY 28
  • 1.2 MARKET DEFINITION 28
  • 1.3 OVERVIEW OF GLOBAL ENTERAL FEEDING FORMULA MARKET 28
  • 1.4 CURRENCY AND PRICING 30
  • 1.5 LIMITATIONS 30
  • 1.6 MARKETS COVERED 30

2 MARKET SEGMENTATION 34

  • 2.1 MARKETS COVERED 34
  • 2.2 GEOGRAPHICAL SCOPE 35
  • 2.3 YEARS CONSIDERED FOR THE STUDY 36
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 37
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
  • 2.6 MULTIVARIATE MODELLING 41
  • 2.7 PRODUCT LIFELINE CURVE 42
  • 2.8 DBMR MARKET POSITION GRID 43
  • 2.9 MARKET APPLICATION COVERAGE GRID 44
  • 2.10 VENDOR SHARE ANALYSIS 45
  • 2.11 SECONDARY SOURCES 46
  • 2.12 ASSUMPTIONS 46

3 EXECUTIVE SUMMARY 47

4 PREMIUM INSIGHTS 50

5 MARKET OVERVIEW 52

  • 5.1 DRIVERS 54
    • 5.1.1 RISING NUMBER OF PRETERM BIRTH 54
    • 5.1.2 GROWING NUMBER OF CHRONIC DISEASES 55
    • 5.1.3 GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY 56
    • 5.1.4 GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION 56
    • 5.1.5 HIGH DEMAND FOR HOME CARE 57
  • 5.2 RESTRAINTS 58
    • 5.2.1 .RISKS ASSOCIATED WITH ENTERAL TUBE FEEDING 58
    • 5.2.2 STRICT REGULATIONS OF USAGE FOR PATIENTS' SAFETY 58
    • 5.2.3 INSUFFICIENT CLINICAL NUTRITION KNOWLEDGE AMONG HEALTH WORKERS 59

  • 5.3 OPPORTUNITIES 60
    • 5.3.1 GROWTH IN HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES 60
    • 5.3.2 TECHNOLOGICAL ADVANCEMENTS IN THE ENTERAL FEEDING DEVICES 61
    • 5.3.3 GOVERNMENT INITIATIVES AND PROGRAMS FOR CREATING AWARENESS 61
    • 5.3.4 INCREASING DEMAND FOR PERSONALIZED MEDICINES 62
  • 5.4 CHALLENGES 62
    • 5.4.1 INSUFFICIENT REIMBURSEMENTS POLICIES 62
    • 5.4.2 LACK OF TRAINED STAFF 63

6 COVID 19 IMPACT ON THE MARKET 64

7 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY PRODUCT 65

  • 7.1 OVERVIEW 66
  • 7.2 STANDARD FORMULAS 68
    • 7.2.1 MONOMERIC 69
    • 7.2.2 POLYMERIC 69
  • 7.3 DISEASE SPECIFIC 69
    • 7.3.1 DIABETIC FORMULAS 70
    • 7.3.2 RENAL FORMULAS 70
    • 7.3.3 HEPATIC FORMULAS 70
    • 7.3.4 PULMONARY FORMULAS 70
    • 7.3.5 OTHERS 72

8 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY APPLICATION 73

  • 8.1 OVERVIEW 74
  • 8.2 CRITICAL CARE 75
  • 8.3 GASTROENTEROLOGY 76
  • 8.4 ONCOLOGY 76
  • 8.5 NEUROLOGY 77
  • 8.6 DIABETES 78
  • 8.7 OTHERS 78

9 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING 80

  • 9.1 OVERVIEW 81
  • 9.2 GASTRIC TUBE FEEDING 83
  • 9.3 NASOGASTRIC TUBE FEEDING 84
  • 9.4 GASTROTOMY TUBE FEEDING 84
  • 9.5 DUODENAL OR JEJUNAL TUBE FEEDING 85

10 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY STAGE 86

  • 10.1 OVERVIEW 87
  • 10.2 ADULT 88
  • 10.3 PEDIATRIC 89

11 GLOBAL ENTERAL FEEDING FORMULA MARKET, BY END USER 90

  • 11.1 OVERVIEW 91
  • 11.2 HOSPITALS 92
  • 11.3 LONG TERM CARE FACILITIES 93
    • 11.3.1 HOME CARE AGENCIES AND HOSPICES 94
    • 11.3.2 NURSING HOMES 94
    • 11.3.3 ASSISTED LIVING FACILITIES 94

12 GLOBAL ENTERAL FEEDING FORMULA MARKET BY GEOGRAPHY 95

  • 12.1 GLOBAL 95
  • 12.2 NORTH AMERICA 101
    • 12.2.1 U.S. 107
    • 12.2.2 CANADA 110
    • 12.2.3 MEXICO 113
  • 12.3 EUROPE 116
    • 12.3.1 GERMANY 122
    • 12.3.2 U.K. 125
    • 12.3.3 FRANCE 128
    • 12.3.4 SPAIN 131
    • 12.3.5 ITALY 134
    • 12.3.6 SWITZERLAND 137
    • 12.3.7 NETHERLAND 140
    • 12.3.8 NORWAY 143
    • 12.3.9 BELGIUM 146
    • 12.3.10 RUSSIA 149
    • 12.3.11 POLAND 152
    • 12.3.12 TURKEY 155
    • 12.3.13 REST OF EUROPE 158
  • 12.4 ASIA PACIFIC 159
    • 12.4.1 CHINA 165
    • 12.4.2 INDIA 168
    • 12.4.3 JAPAN 171
    • 12.4.4 SOUTH KOREA 174
    • 12.4.5 AUSTRALIA 177
    • 12.4.6 SINGAPORE 180
    • 12.4.7 THAILAND 183
    • 12.4.8 MALAYSIA 186
    • 12.4.9 INDONESIA 189
    • 12.4.10 PHILIPPINES 192
    • 12.4.11 REST OF ASIA-PACIFIC 195
  • 12.5 SOUTH AMERICA 196
    • 12.5.1 BRAZIL 202
    • 12.5.2 ARGENTINA 205
    • 12.5.3 COLOMBIA 208
    • 12.5.4 CHILE 211
    • 12.5.5 REST OF SOUTH AMERICA 214
  • 12.6 MIDDLE EAST & AFRICA 215
    • 12.6.1 SOUTH AFRICA 221
    • 12.6.2 REST OF MIDDLE EAST & AFRICA 224

13 GLOBAL ENTERAL FEEDING FORMULA MARKET, COMPANY LANDSCAPE 225

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL 225
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 226
  • 13.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 227
  • 13.4 COMPANY SHARE ANALYSIS: EUROPE 228

14 SWOT ANALYSIS 229

15 COMPANY PROFILES 230

  • 15.1 ABBOTT 230
    • 15.1.1 COMPANY SNAPSHOT 230
    • 15.1.2 REVENUE ANALYSIS 230
    • 15.1.3 COMPANY SHARE ANALYSIS 231
    • 15.1.4 PRODUCT PORTFOLIO 231
    • 15.1.5 RECENT DEVELOPMENT 232
  • 15.2 NESTLE HEALTH SCIENCE 233
    • 15.2.1 COMPANY SNAPSHOT 233
    • 15.2.2 REVENUE ANALYSIS 233
    • 15.2.3 COMPANY SHARE ANALYSIS 234
    • 15.2.4 PRODUCT PORTFOLIO 234
    • 15.2.5 RECENT DEVELOPMENTS 235
  • 15.3 MEIJI HOLDINGS CO., LTD. 236
    • 15.3.1 COMPANY SNAPSHOT 236
    • 15.3.2 REVENUE ANALYSIS 236
    • 15.3.3 COMPANY SHARE ANALYSIS 237
    • 15.3.4 PRODUCT PORTFOLIO 237
    • 15.3.5 RECENT DEVELOPMENT 237
  • 15.4 B. BRAUN MELSUNGEN AG 238
    • 15.4.1 COMPANY SNAPSHOT 238
    • 15.4.2 REVENUE ANALYSIS 238
    • 15.4.3 COMPANY SHARE ANALYSIS 239
    • 15.4.4 PRODUCT PORTFOLIO 239
    • 15.4.5 RECENT DEVELOPMENT 240
  • 15.5 FRESENIUS KABI LTD (A SUBSIDIARY OF FRESENIUS SE & CO. KGAA) 241
    • 15.5.1 COMPANY SNAPSHOT 241
    • 15.5.2 REVENUE ANALYSIS 241
    • 15.5.3 PRODUCT PORTFOLIO 242
    • 15.5.4 RECENT DEVELOPMENTS 242
  • 15.6 GLOBAL HEALTH PRODUCTS, INC. 244
    • 15.6.1 COMPANY SNAPSHOT 244
    • 15.6.2 PRODUCT PORTFOLIO 244
    • 15.6.3 RECENT DEVELOPMENT 244
  • 15.7 HORMEL FOODS CORPORATION 245
    • 15.7.1 COMPANY SNAPSHOT 245
    • 15.7.2 PRODUCT PORTFOLIO 245
    • 15.7.3 RECENT DEVELOPMENT 245
  • 15.8 MEAD JOHNSON & COMPANY, LLC. 246
    • 15.8.1 COMPANY SNAPSHOT 246
    • 15.8.2 BRAND PORTFOLIO 246
    • 15.8.3 RECENT DEVELOPMENT 246
  • 15.9 MEDLINE INDUSTRIES, INC 247
    • 15.9.1 COMPANY SNAPSHOT 247
    • 15.9.2 PRODUCT PORTFOLIO 247
    • 15.9.3 RECENT DEVELOPMENTS 248
  • 15.10 MEDTRITION, INC. 249
    • 15.10.1 COMPANY SNAPSHOT 249
    • 15.10.2 PRODUCT PORTFOLIO 249
    • 15.10.3 RECENT DEVELOPMENT 250
  • 15.11 NUTRICIA ADVANCED MEDICAL NUTRITION 251
    • 15.11.1 COMPANY SNAPSHOT 251
    • 15.11.2 PRODUCT PORTFOLIO 251
    • 15.11.3 RECENT DEVELOPMENTS 252
  • 15.12 NUTRITIONAL MEDICINALS, LLC 253
    • 15.12.1 COMPANY SNAPSHOT 253
    • 15.12.2 PRODUCT PORTFOLIO 253
    • 15.12.3 RECENT DEVELOPMENT 253
  • 15.13 REAL FOOD BLENDS 254
    • 15.13.1 COMPANY SNAPSHOT 254
    • 15.13.2 PRODUCT PORTFOLIO 254
    • 15.13.3 RECENT DEVELOPMENTS 254
  • 15.14 VICTUS, INC 256
    • 15.14.1 COMPANY SNAPSHOT 256
    • 15.14.2 PRODUCT PORTFOLIO 256
    • 15.14.3 RECENT DEVELOPMENT 256

16 QUESTIONNAIRE 257

17 RELATED REPORTS 260

LIST OF FIGURES

LIST OF FIGURES

  • FIGURE 1 GLOBAL ENTERAL FEEDING FORMULA MARKET: SEGMENTATION 34
  • FIGURE 2 GLOBAL ENTERAL FEEDING FORMULA MARKET: DATA TRIANGULATION 37
  • FIGURE 3 GLOBAL ENTERAL FEEDING FORMULA MARKET: DROC ANALYSIS 38
  • FIGURE 4 GLOBAL ENTERAL FEEDING FORMULA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 39
  • FIGURE 5 GLOBAL ENTERAL FEEDING FORMULA MARKET: COMPANY RESEARCH ANALYSIS 39
  • FIGURE 6 GLOBAL ENTERAL FEEDING FORMULA MARKET: INTERVIEW DEMOGRAPHICS 40
  • FIGURE 7 GLOBAL ENTERAL FEEDING FORMULA MARKET: DBMR MARKET POSITION GRID 43
  • FIGURE 8 GLOBAL ENTERAL FEEDING FORMULA MARKET: MARKET APPLICATION COVERAGE GRID 44
  • FIGURE 9 GLOBAL ENTERAL FEEDING FORMULA MARKET: VENDOR SHARE ANALYSIS 45
  • FIGURE 10 GLOBAL ENTERAL FEEDING FORMULA MARKET: SEGMENTATION 48
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ENTERAL FEEDING FORMULA MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027 49
  • FIGURE 12 RISING NUMBER OF PRETERM BIRTH AND GROWING NUMBER OF CHRONIC DISEASES ARE EXPECTED TO DRIVE THE GLOBAL ENTERAL FEEDING FORMULA MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 50
  • FIGURE 13 STANDARD FORMULAS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ENTERAL FEEDING FORMULA MARKET IN 2020 & 2027 50
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING REGION FOR ENTERAL FEEDING FORMULA MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027 51
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL ENTERAL FEEDING FORMULA MARKET 53
  • FIGURE 16 NUMBER OF PRETERM BIRTHS IN FEW COUNTRIES, 2018 54
  • FIGURE 17 DISTRIBUTION OF POPULATION AGED 65 YEARS OR OVER BY REGION, 2019 (%) 57
  • FIGURE 18 HEALTH EXPENDITURE, PERCENTAGE SHARE OF GROSS DOMESTIC PRODUCT 60
  • FIGURE 19 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY PRODUCT, 2019 66
  • FIGURE 20 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY APPLICATION, 2019 74
  • FIGURE 21 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY TYPE OF TUBE FEEDING, 2019 81
  • FIGURE 22 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY STAGE, 2019 87
  • FIGURE 23 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY END USER, 2019 91
  • FIGURE 24 GLOBAL ENTERAL FEEDING FORMULA MARKET: SNAPSHOT (2019) 95
  • FIGURE 25 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY COUNTRY (2019) 96
  • FIGURE 26 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY COUNTRY (2020 & 2027) 96
  • FIGURE 27 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY COUNTRY (2019 & 2027) 97
  • FIGURE 28 GLOBAL ENTERAL FEEDING FORMULA MARKET: BY PRODUCT (2020-2027) 97
  • FIGURE 29 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY SNAPSHOT(2019) 101
  • FIGURE 30 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY COUNTRY (2019) 102
  • FIGURE 31 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY COUNTRY (2020-2027) 102
  • FIGURE 32 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY COUNTRY (2019-2027) 103
  • FIGURE 33 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY PRODUCT (2020-2027) 103
  • FIGURE 34 EUROPE ENTERAL FEEDING FORMULA MARKET SNAPSHOT (2019) 116
  • FIGURE 35 EUROPE ENTERAL FEEDING FORMULA MARKET BY COUNTRY (2019) 117
  • FIGURE 36 EUROPE ENTERAL FEEDING FORMULA MARKET BY COUNTRY (2020 & 2027) 117
  • FIGURE 37 EUROPE ENTERAL FEEDING FORMULA MARKET BY COUNTRY (2019 & 2027) 118
  • FIGURE 38 EUROPE ENTERAL FEEDING FORMULA MARKET: BY PRODUCT (2020-2027) 118
  • FIGURE 39 ASIA PACIFIC ENTERAL FEEDING FORMULA MARKET:BY SNAPSHOT(2019) 159
  • FIGURE 40 ASIA PACIFIC ENTERAL FEEDING FORMULA MARKET:BY COUNTRY(2019) 160
  • FIGURE 41 ASIA PACIFIC ENTERAL FEEDING FORMULA MARKET:BY COUNTRY(2020-2027) 160
  • FIGURE 42 ASIA PACIFIC ENTERAL FEEDING FORMULA MARKET:BY COUNTRY(2019-2027) 161
  • FIGURE 43 ASIA PACIFIC ENTERAL FEEDING FORMULA MARKET: BY PRODUCT (2020-2027) 161
  • FIGURE 44 SOUTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY SNAPSHOT(2019) 196
  • FIGURE 45 SOUTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY COUNTRY(2019) 197
  • FIGURE 46 SOUTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY COUNTRY(2020-2027) 197
  • FIGURE 47 SOUTH AMERICA ENTERAL FEEDING FORMULA MARKET:BY COUNTRY(2019-2027) 198
  • FIGURE 48 SOUTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY PRODUCT (2020-2027) 198
  • FIGURE 49 MIDDLE EAST & AFRICA ENTERAL FEEDING FORMULA MARKET:BY SNAPSHOT(2019) 215
  • FIGURE 50 MIDDLE EAST & AFRICA ENTERAL FEEDING FORMULA MARKET:BY COUNTRY(2019) 216
  • FIGURE 51 MIDDLE EAST & AFRICA FEEDING FORMULA MARKET:BY COUNTRY(2020-2027) 216
  • FIGURE 52 MIDDLE EAST & AFRICA FEEDING FORMULA MARKET:BY COUNTRY(2019-2027) 217
  • FIGURE 53 MIDDLE EAST & AFRICA FEEDING FORMULA MARKET: BY PRODUCT (2020-2027) 217
  • FIGURE 54 GLOBAL ENTERAL FEEDING FORMULA MARKET: COMPANY SHARE 2019 (%) 225
  • FIGURE 55 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: COMPANY SHARE 2019 (%) 226
  • FIGURE 56 ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET: COMPANY SHARE 2019 (%) 227
  • FIGURE 57 EUROPE ENTERAL FEEDING FORMULA MARKET: COMPANY SHARE 2019 (%) 228